No new cases of cVDPV2 were reported this week. The most recent case (by date of onset) is 9 September 2017 from Mayadeen district.
The total number of confirmed cVDPV2 cases remains 70.
Planning continues for the second phase of the outbreak response. The Syrian Ministry of Health has requested additional doses of mOPV2 and IPV for two further immunization rounds.
Training of health staff for the assessment of cold chain capacity across the country is ongoing in Damascus. Health staff have been trained on mobile data collection. All accessible health facilities will be assessed starting 10 December.
Since confirmation of the outbreak, World Health Organization and UNICEF have coordinated with the Government of Syria and local authorities to reach more than 350,000 resident, refugee and internally displaced children with mOPV2 through two mass vaccination rounds in Deir Ez-Zor and Raqqa governorates.
In addition to focused mOPV2 campaigns, IPV has been offered to children aged 2-23 months to boost immunity in infected and high risk areas of Deir Ez-Zor, Raqqa, Aleppo, Idleb, Hama and Homs governorates and areas of Damascus, Rural Damascus and Hasakah where families from outbreak zones have moved during the response.
Neighboring countries have utilized IPV in targeted vaccination activities, particularly in areas with high concentration of Syrian refugees, to boost immunity.